LiveWorld Bank Approves $280 Million Health Project for Kerala
Kerala is set to receive a major boost to its healthcare system. This comes as the World Bank has approved a $280 million programme to...
Category : HEALTHCARE
TN Revokes Sresan Pharma’s License Over Contaminated Coldrif
The Tamil Nadu government has permanently revoked the manufacturing license of Sresan Pharmaceuticals, the company responsible for the contaminated cough syrup Coldrif. They have also...
WHO Seeks Clarity from India on Export of Coldrif Cough Syrup
The World Health Organisation (WHO) on 8th October asked Indian authorities to clarify whether the Coldrif cough syrup, linked to several child deaths, had been...
Nasal Vaccine Gets Approval for Booster Doses
Bharat Biotech’s intranasal vaccine will be used in India’s Covid-19 vaccination programme. On December 23, 2022, Union Health Minister Mansukh Mandaviya said the vaccine was...
Glenmark Pharma Signs Settlement Agreement with Pfizer Over Cancer Drug
On Tuesday, Glenmark Pharmaceuticals said it had reached a settlement with Pfizer over a cancer treatment drug.The Mumbai-based drugmaker and its US subsidiary signed a...
Aurobindo Pharma Arm Gets USFDA Approval for Fungal Infection Treatment Injection
Aurobindo Pharma said on Friday that its wholly-owned subsidiary Eugia Pharma Specialties had received final approval from the United States Food and Drug Administration (USFDA)...
Bajaj Healthcare Completes USFDA Pre-Approval Inspection of Vadodara Facility
On Friday, Bajaj Healthcare Ltd said it has successfully completed a pre-approval inspection by US health regulators at its active pharmaceutical ingredient plant in Vadodara,...
Pfizer Says COVID-19 Vaccine Will Cost $110-$130 Per Dose
Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the US government stops buying the vaccine, but the drugmaker said...
Lupin Partners with Global Agencies to Support TB Prevention Treatment Initiatives
On Friday, Pharmaceutical company Lupin said that it has partnered with Unitaid, the Aurum Institute, the Clinton Health Access Initiative (CHAI) and other global procurement...
Glenmark Pharma Launches Drug to Treat Type 2 Diabetes in Adults
Glenmark Pharmaceuticals announced on October 6 that it had become the first company in India to launch thiazolidinedione (lobeglitazone) for adults with type 2 diabetes....